Treatment of Pneumonia
Pneumonia is an infection that inflames the air sacs (alveoli) in one or both lungs, which may fill with fluid or pus. It can be caused by bacteria, viruses, or fungi and ranges from mild to life-threatening.
Managing Pneumonia effectively requires a combination of medical treatment, lifestyle modification, and regular monitoring. With a structured management plan, most people with Pneumonia can maintain a good quality of life and prevent serious complications.
First-Line Treatment Principles
- ✓Identify and address triggers (allergens, occupational exposures, smoking)
- ✓Inhaled corticosteroid (ICS) is cornerstone of persistent asthma management
- ✓Short-acting bronchodilator (SABA/SAMA) for rescue symptom relief
- ✓Stepwise therapy escalation: ICS → ICS/LABA → add-on biologics if severe
- ✓Pulmonary rehabilitation for COPD (GOLD stage B/C/D)
What to Do Now
- Learn your personal risk factors for Pneumonia (family history, age, lifestyle)
- Attend regular health check-ups and screening tests appropriate for your age and risk
- Track new or changing symptoms, especially those associated with Pneumonia
- Use our AI symptom checker to assess whether your symptoms fit an early Pneumonia pattern
- Discuss preventive strategies and early monitoring with your GP
- Build a personalised management plan with your GP or specialist
- Adhere consistently to prescribed medications — do not stop without medical advice
- Adopt a Pneumonia-appropriate diet (anti-inflammatory, low-glycaemic, or disease-specific)
Medications Used in Pneumonia
Amoxicillin is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.
Amoxicillin Clavulanate is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.
Ampicillin is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.
Piperacillin is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.
Flucloxacillin is a narrow-spectrum, penicillinase-resistant penicillin antibiotic active mainly against Gram-positive bacteria such as Staphylococcus aureus and streptococci. It is used for skin and soft-tissue, bone and joint, and other staphylococcal infections. It has essentially no activity against the Gram-negative bacteria (such as E. coli) that cause most urinary tract infections, so it is not used to treat UTIs.
Dicloxacillin is a narrow-spectrum, penicillinase-resistant penicillin antibiotic active mainly against Gram-positive bacteria such as Staphylococcus aureus. It is used for skin and soft-tissue and other staphylococcal infections. It has essentially no activity against the Gram-negative bacteria (such as E. coli) that cause most urinary tract infections, so it is not used to treat UTIs.
Phenoxymethylpenicillin (penicillin V) is a narrow-spectrum oral penicillin antibiotic used mainly for streptococcal infections such as strep throat and for prophylaxis (e.g. rheumatic fever, asplenia). It has poor activity against the Gram-negative uropathogens (such as E. coli) that cause most urinary tract infections and is not a recommended treatment for UTIs.
Benzylpenicillin (penicillin G) is a narrow-spectrum injectable penicillin antibiotic used for streptococcal, meningococcal and other susceptible Gram-positive infections. It is not standard therapy for typical urinary tract infections, which are usually caused by Gram-negative bacteria such as E. coli; its main urinary niche is a Group B Streptococcus (GBS) UTI, an uncommon and specific context.
Non-Pharmacological Management
- •Smoking cessation — single most effective intervention in COPD (slows FEV1 decline)
- •Trigger avoidance: dust mites, pet dander, pollen, mould, cold air, NSAIDs
- •Annual influenza vaccination; pneumococcal vaccination in high-risk patients
- •Pulmonary rehabilitation: supervised exercise + education programme
- •Breathing techniques (pursed-lip breathing, diaphragmatic breathing) for COPD
- •Optimise nutritional status; treat obesity as it worsens respiratory mechanics
- •Supplemental oxygen if SpO2 <88% at rest or <92% with significant desaturation on exertion
Treatment Goals
Monitoring Parameters
- ◆Spirometry (FEV1, FVC, FEV1/FVC): baseline and annually in COPD; assessment after treatment changes
- ◆Peak expiratory flow (PEF): self-monitoring in asthma (symptom-based or twice daily)
- ◆Oxygen saturation (SpO2): with exacerbations or progressive disease
- ◆Symptom scores: ACQ/ACT (asthma), CAT/mMRC (COPD) at each visit
- ◆Exacerbation frequency: a key driver of treatment escalation in both asthma and COPD
- ◆Inhaler technique review at every clinical encounter
Red Flags — When to Escalate
- ⚠Any of the characteristic symptoms of Pneumonia — even mild — in a high-risk individual
- ⚠Progressive worsening of early warning signs over weeks
- ⚠Laboratory abnormalities (e.g., blood sugar, inflammatory markers) without full symptoms
- ⚠Unexplained weight loss, night sweats, or fatigue persisting >2 weeks
- ⚠Strong family history of Pneumonia combined with new relevant symptoms
- ⚠Sudden worsening of Pneumonia symptoms despite established treatment
Escalation Criteria
- →Severe acute asthma: PEFR <50% best → hospitalisation, IV corticosteroids, nebulised bronchodilators
- →COPD acute exacerbation: worsening dyspnoea + purulent sputum → antibiotics + systemic corticosteroids
- →Inadequate control on ICS/LABA → consider add-on LAMA, biologics (severe eosinophilic asthma), or specialist referral
- →New respiratory failure (PaO2 <8 kPa, rising CO2) → urgent hospital assessment
Special Populations
Clinical Insights
Compare With Similar Conditions
Not sure about your symptoms?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.
Use AI Symptom Checker →